Allianz Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Allianz Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-404,771	Closed	-$11.6M	–	2856
2018 Q4	$11.6M	Buy	404,771 +64,771	+19%	+$1.84M	0.01%	1044
2018 Q3	$9.48M	Hold	340,000	–	–	0.01%	1284
2018 Q2	$9.49M	Hold	340,000	–	–	0.01%	1272
2018 Q1	$8.45M	Hold	340,000	–	–	0.01%	1321
2017 Q4	$8.24M	Hold	340,000	–	–	0.01%	1405
2017 Q3	$9.38M	Buy	+340,000	New	+$9.07M	0.01%	1348
2016 Q2	–	Sell	-455,249	Closed	-$6.82M	–	2652
2016 Q1	$6.82M	Buy	+455,249	New	+$7.63M	0.01%	1316
2013 Q4	–	Sell	-385,936	Closed	-$5.08M	–	1936
2013 Q3	$5.08M	Sell	385,936 -289,400	-43%	-$3.8M	0.01%	920
2013 Q2	$9.64M	Buy	+675,336	New	+$8.49M	0.01%	648

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Allianz Asset Management's NXTM Position: Q1 2019 in Review

Allianz Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 404,771 shares — an estimated $11.6M sold.

Allianz Asset Management first reported a position in NXTM in Q2 2013 and held it in 9 quarters. The position peaked at $11.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Allianz Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Allianz Asset Management sold 404,771 NxStage Medical Inc. shares in Q1 2019, an estimated $11.6M.
Allianz Asset Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 9 quarters.
Allianz Asset Management's NxStage Medical Inc. position peaked at $11.6M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Allianz Asset Management's 13F filing for Q1 2019, filed 13 May 2019.